
bioProtonics provides Magnetic Resonance Histopathology (MRH) software that lets radiologists detect micro-level tissue changes non-invasively as an alternative to surgical biopsy. It uses a proprietary MRI pulse sequence combined with AI analysis to extract sub‑1mm tissue texture metrics and compare them to biopsy-derived patterns. The solution is delivered as SaaS software that integrates with DICOM workflows, adds about 90 seconds to scan time, and requires no additional hardware. MRH is operable by standard MRI technicians and is compatible across MRI platforms, enabling deployment in clinical radiology settings. The product targets early-detection use cases across specialties such as oncology and urology and scales via cloud-based analysis and integration with existing imaging infrastructure.

bioProtonics provides Magnetic Resonance Histopathology (MRH) software that lets radiologists detect micro-level tissue changes non-invasively as an alternative to surgical biopsy. It uses a proprietary MRI pulse sequence combined with AI analysis to extract sub‑1mm tissue texture metrics and compare them to biopsy-derived patterns. The solution is delivered as SaaS software that integrates with DICOM workflows, adds about 90 seconds to scan time, and requires no additional hardware. MRH is operable by standard MRI technicians and is compatible across MRI platforms, enabling deployment in clinical radiology settings. The product targets early-detection use cases across specialties such as oncology and urology and scales via cloud-based analysis and integration with existing imaging infrastructure.